title: Tropisetron (Navoban) compared with alizapride in the control of emesis induced by cyclophosphamide-containing regimens.
authors.forename: A
authors.initials: A
authors.lastname: De Nigris
authors.forename: G
authors.initials: G
authors.lastname: Paladini
authors.forename: F
authors.initials: F
authors.lastname: Giosa
authors.forename: C
authors.initials: C
authors.lastname: Sfeir
authors.forename: M G
authors.initials: MG
authors.lastname: Pagan
authors.forename: C
authors.initials: C
authors.lastname: Maltoni
mesh_terms: D000932:Antiemetics / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects*; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D009325:Nausea / Q000517:prevention & control*; D011759:Pyrrolidines / Q000627:therapeutic use; D000077526:Tropisetron; D014839:Vomiting / Q000517:prevention & control*
chemical_list: D000932:Antiemetics; D007211:Indoles; D011759:Pyrrolidines; D000077526:Tropisetron; D003520:Cyclophosphamide; C033968:alizapride